mcK6A1

Description: mcK6A1 serves as an inhibitor of amyloid-beta (Abeta) aggregation, selectively binding to the 16KLVFFA21 fragment of Abeta42, leading to the formation of an extended beta-sheet structure and preventing the formation of Abeta42 oligomers. This compound is valuable for research into Alzheimer's disease and other amyloid-related disorders. Target: Beta Amyloid. Smiles: C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCCC[C@@H](C(=O)NNC(=O)C2=C(C=CC(=C2)NC(=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCCC[C@@H](C(=O)N1)N)CC3=CC=C(C=C3)O)CCCCN)OC)N)CCCCN)CC4=CC=C(C=C4)O)CC5=CNC6=CC=CC=C65)CC(C)C)O